Introduction
Barrett's esophagus (BE) occurs at the gastroesophageal junction and is characterized by the replacement of the normal esophageal squamous epithelium with a specialized intestinal columnar epithelium. It is of clinical importance because it is a premalignant condition that considerably increases an individual's risk for esophageal adenocarcinoma (EAC) (1, 2) . However, the molecular events that give rise to BE remain to be elucidated.
The intestinal cell phenotype that characterizes BE is normally manifested only in the small intestine and colon. However, intestinal metaplasia precedes the development of cancer in several gastrointestinal tissues (3, 4) . Typically, expression of the intestine-specific transcription factor Cdx2 is detected early in these preneoplastic lesions (5) (6) (7) (8) (9) . Cdx2 is a caudal-related homeobox transcription factor. It is well known for its role in promoting intestine-specific gene expression and intestinal cell differentiation (10) . A causal link between the ectopic expression of Cdx2 and gastric intestinal metaplasia has been established using a transgenic mouse approach (11, 12) . However, similar proof for Cdx2 as the causative factor in BE has remained elusive.
One limitation in the study of the genesis of BE has been the lack of suitable experimental cell culture models. The cell culture models used to date have largely been human BE tissue explants and EAC cell lines, with some recent work in primary Barrett's cell lines. Acid exposure has been suggested to enhance proliferation and promote intestinal differentiation based on studies with these models (13) (14) (15) (16) . Barrett's cell lines have recently been developed (17, 18) . While useful for studies of the progression from BE to EAC, they are less useful for understanding how BE emerges within the normal esophageal epithelium.
We and others have sought to establish whether esophageal squamous keratinocytes can be induced to transdifferentiate in vitro into BE epithelial cells. Chronic acid and bile acid treatment of rat and murine esophageal keratinocytes induces low levels of Cdx2 expression but does not induce an intestinal cell phenotype (19, 20) . More recently, it was demonstrated that primary human esophageal keratinocytes treated with bone morphogenetic protein 4 began expressing BE-associated cytokeratins and a more intestinalized pattern of gene expression (21) . In another study using immortalized human esophageal keratinocytes (HET1A), Cdx2 expression was associated with increased cell proliferation and an intestinal pattern of gene expression (22) . One limitation of this study is that HET1A cells are immortalized by ectopic expression of the SV40 T antigen, a viral oncoprotein that inactivates p53 and the retinoblastoma protein (pRb), among other targets (23) .
Given these previous reports, we hypothesized that Cdx2 expression in normal human keratinocytes would induce an intestinal pattern of gene expression similar to that seen in human BE. In the present study, we identify several critical parameters required to intestinalize a human esophageal cell line known as EPC-human telomerase reverse transcriptase (hTERT). Expression of Cdx2 alone in these cells did not induce intestinalization but rather severely inhibited cell proliferation. However, agents that promoted chromatin remodeling synergized with Cdx2 to enhance the expression of intestine-specific and BE-associated genes. These agents also uniformly induced cell senescence. We conclude that ectopic proliferation signals, alterations in epigenetic gene regulation and the inhibition of tumor suppressor mechanisms are necessary for Cdx2-mediated intestinalization of normal human esophageal keratinocytes.
Materials and methods

Cell culture and transfections
Immortalized human primary esophageal epithelial cells (EPC-hTERT) were developed and maintained as described previously (24, 25) . The pBPSTR, pBabe-puro-p53R175H, MIGR1 and MIGR-Cdx2 retroviral vectors were described previously (26) (27) (28) . The MIGR1 vector includes an internal ribosomal entry site and a 3# green fluorescent protein (GFP) complementary DNA (cDNA) with a 5# multicloning site into which a Cdx2 cDNA was cloned. We utilized the pBPSTR retroviral vector to express cyclin D1 under the control of a Tet-Off promoter (28) . Retroviral vectors were transfected into Phoenix-Ampho packaging cells (gift of Dr Garry Nolan, Stanford University, Palo Alto, CA) using Lipofectamine TM 2000 reagent (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. Infectious retroviral supernatants were isolated at 48 h, purified as described elsewhere (29) and stored at À70°C. Cells infected with the MIGR1-based retrovirus can be identified and sorted by their GFP fluorescence described (26) .
EPC-hTERT cells were infected with pBPSTR-D1 virus, subjected to puromycin selection and then infected with MIGR-Cdx2 and MIGR1 retroviral vectors. GFP-expressing cells were then isolated by fluorescence-activated cell sorting. For the 5-aza-2-deoxycytidine (5-AzaC) treatment, cells were plated at a density of 5 Â 10 5 per 10 cm dish. The cells were grown in growth medium without or with the demethylating agent 5-AzaC (1, 5 and 10 lmol/l; Sigma, St Louis, MO) for 120 h. The medium was replaced with fresh medium every other day. The equivalent volume of vehicle (50% dimethyl sulfoxide for 5-AzaC) was applied as control.
Cell proliferation assays
Cell proliferation was determined using two methods: (i) the WST-1 assay and (ii) [H 3 ]thymidine incorporation. Cell proliferation was quantified by colorimetry based on the metabolic cleavage of the tetrazolium salt WST-1 in viable cells as recommended by the manufacturer (Roche Applied Science, Mannheim, Germany). To determine cell proliferation by [H 3 ]thymidine incorporation, the stably infected cells were incubated with [H 3 ]thymidine (1 lCi) (PerkinElmer Life and Analytical Sciences, Shelton, CT) and cells were incubated for 24 h. Cells were harvested for DNA synthesis and cell proliferation analysis was performed using an LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter, Fullerton, CA). For each cell line, the mean value of six separate experiments was calculated. The assay was repeated at least three times.
Tissue specimens
Fresh tissues were obtained from the Hospital of the Pennsylvania through the Cooperative Human Tissue Network. Fresh specimens were frozen in liquid nitrogen immediately after surgery and stored at À80°C for RNA or protein analysis. Formalin-fixed, paraffin-embedded human sections were used for the immunohistochemical study. Histological analysis was performed by pathologists using standard diagnostic criteria and patient's informed consent was obtained by the Cooperative Human Tissue Network participating hospitals in accordance with institutional review board standards and guidelines. Six paired human esophageal samples consisting of BE and matched normal or benign esophageal tissues (from the margins of the excised Barrett's) were obtained. Three normal colon biopsies were obtained from patients undergoing surgical resections.
RNA isolation and real-time quantitative polymerase chain reaction analysis Total RNA was isolated from sorted GFP-expressing cells, human BE tissue and matched normal controls using the RNAeasy kit (Qiagen, Valencia, CA). Five microgram of total RNA was used for cDNA synthesis using the SuperScript TM First-Strand Synthesis Kit (Invitrogen). Reverse transcriptasenegative controls were included. Primer sequences for polymerase chain reaction (PCR) are available in supplementary Table I (available at Carcinogenesis Online). For the reverse transcription (RT)-PCR, cDNA and primers were mixed with SYBR-green PCR Master Mix (Applied Biosystems) and then assayed in an ABI Prism 7000 sequence detection system as directed by the manufacturer. A ribosomal phosphoprotein, 36B4, was used as the normalization control. Fold change in RNA levels was calculated from the C t values using the formula described previously (26, 30) . The DDC t values for each gene were averaged across the RNA pools, standard deviations were calculated and statistical comparisons were performed using analysis of variance and Tukey Rank Mean testing. These values were then converted to fold change to graphically report the findings.
Protein extraction and western blot analysis Whole-cell extract was prepared as described (31) . Protein concentration of samples and bovine serum albumin standard was determined using the BCA TM protein assay kit (Pierce Biotechnology, Rockford, IL). Primary antibodies used included: anti-Cdx2 IgG1 (clone CDX2-88) (1:1000; BioGenex, San Ramon, CA), anti-downregulated in adenoma (DRA) [1:1000; Dr Soleimani, University of Cincinnati Medical Center (UCMC) (32)], anti-Naþ/Hþ exchanger 2 (NHE2) (1:1000, AB3084; Chemicon, Temecula, CA), anti-villin IgG1 (1:500, V34420-150; BD Transduction Laboratories, San Diego, CA), anti-p21 (1:200, sc-397; Santa Cruz Biotechnology, Santa Cruz, CA), anti-p16 (1:5000; gift from Gregory H.Enders, Fox Chase Cancer Center), anti-tubulin (1:4000; Vector Laboratories, Burlingame, CA) and anti-actin (1:1000; Sigma-Aldrich, St. Louis, MO). The secondary antibodies used were all from Sigma-Aldrich and used at 1:3000. Targeted proteins were visualized using an enhanced chemiluminescence detection system (ECL Plus; Amersham Pharmacia Biotech, Buckingham, UK) and exposed to Blue Lite Autorad film (ISC-BioExpress, Kaysville, UT). For quantitative western blotting analysis, the signals were visualized by the STORM840-Scanner phosphoimager (Amersham Biosciences, Piscataway, NJ) following the manufacturer's instructions, and the appropriate protein bands were quantified using ImageQuant Version 5.2 software (Amersham Biosciences).
Senescence-associated b-galactosidase staining To determine if the cells had undergone senescence, we used the Senescence b-Galactosidase Staining Kit (Cell Signaling Technology, Beverly, MA) according to the manufacturer's protocol. Cells stained for senescence-associated b-galactosidase activity were scored by counting five high-power fields.
Immunohistochemistry
Immunostaining assay was performed as described previously (33) . In brief, paraffin-embedded sections (6 lm) were pretreated with xylene and then boiled in a microwave oven in 10 mmol/l citric acid buffer. Endogenous peroxidases were quenched using hydrogen peroxide before sections were incubated in avidin D blocking reagent and biotin blocking reagent. Sections were incubated with primary anti-DRA (32) (1:250; gift from Dr Soleimani, UCMC) and anti-NHE2 (diluted 1:250; Chemicon International), followed by incubation with secondary antibodies. Immunohistochemistry was carried out using the Vectastain Elite kit (Vector Laboratories) following the manufacturer's protocol. The signal was then developed using the 3,3#-diaminobenzidine substrate kit for peroxidases (Vector Laboratories). Stained objects were examined with a Nikon microscope and imaged with a digital camera at indicated magnifications. Normal colon sections were used as a positive control for DRA/SLC26a3 and NHE2. As negative controls, parallel sections were similarly processed without the respective primary antibody for each immunostaining experiment.
Results
We have subcloned a Cdx2 cDNA into an Murine Stem Cell Virus-based retroviral vector to express Cdx2. This vector, called MIGR1, has a GFP cDNA as the selectable marker. The virus we produced, called MIGR-Cdx2, has been successfully used to establish stable Cdx2 expression in colon cancer cells (26, 27) . This vector expresses both GFP and Cdx2 in a single, bicistronic messenger RNA (mRNA). Retroviral infection and gene expression are established by following GFP protein expression. We therefore used this vector to express Cdx2 in normal human esophageal keratinocytes immortalized by the ectopic expression of human telomerase, called EPC-hTERT cells (24, 25) . Unlike our experience with colon cancer cells, we found it difficult to establish stable Cdx2 expression in the EPC-hTERT cells. Within 72 h of infection by the retrovirus, we could see abundant GFP-expressing EPChTERT cells. However, after 7-10 days in culture, a noticeable decline in GFP expression occurred in those cells in which Cdx2 was coexpressed ( Figure 1A ). We attempted to sort at 72 h for GFP-expressing cells by flow cytometry to establish a Cdx2-expressing cell line. Although we were able to isolate 25 000 GFP þ cells to start, the population that grew out uniformly had lost GFP and Cdx2 expression. This was not observed when using the empty MIGR1 vector as a control (data not shown).
Based on our work in colon cancer cells, where we studied an antiproliferative effect of Cdx2, we suspected that Cdx2 expression was limiting proliferation in our EPC-hTERT cells (10, 34, 35) . To explore this further, we followed GFP expression in EPC-hTERT cells infected by MIGR-Cdx2 virus over 10 days. At 48 h, there was approximately the same number of GFP þ EPC-hTERT cells after infection with the MIGR-Cdx2 virus and the empty vector MIGR1 control. Whereas the percentage of GFP þ cells increased from 3 to 12% in the EPC-hTERT cells receiving the control MIGR1 vector, cells infected with the MIGR-Cdx2 vector gradually lost all GFP expression ( Figure 1A ). By day 5, there was a statistically significant difference between the Cdx2-expressing and control cells, and virtually all GFP þ /Cdx2 þ cells were lost by day 10 ( Figure 1B ). In summary, Cdx2 expression cannot be sustained in a population of normally proliferating esophageal keratinocytes.
Ectopic cyclin D1 expression can support Cdx2 in normal human esophageal keratinocytes There was no evidence for increased cell death or apoptosis in those GFP þ /Cdx2 þ cells at 72 h after infection (data not shown). Rather, it appeared that the GFP þ /Cdx2 þ cells were either less proliferative and thereby outcompeted by the other cells or that the retroviral vector was silenced or lost by an unknown mechanism. In colon cancer cells, we had previously observed a reduction in cell proliferation associated with Cdx1 or Cdx2 expression (35) . Mechanistically, this was due to a loss in cyclin D1 expression (34) . We therefore utilized the pBPSTR retroviral vector to express cyclin D1 under the control of a Tet-Off promoter in the EPC-hTERT parental cells (28) . Cyclin D1 levels were increased in the EPC-hTERT cells after infection with the pBPSTR retroviral vector (Figure 2A ). The addition of doxycyclin to the cell culture medium resulted in a reduction of cyclin D1 levels to that of the parental EPC-hTERT cells.
EPC-hTERT.D1 cells were subsequently infected with either the MIGR1 or MIGR-Cdx2 retroviruses. GFP þ cells were isolated by Cdx2 transdifferentiation of esophageal keratinocytes fluorescence-activated cell sorting for further study. Unlike our previous attempts, Cdx2 expression was established and maintained over multiple passages ( Figure 2B and data not shown). The Cdx2-expressing cells appeared to proliferate slower than the EPC-hTERT.D1.MIGR1 control cells. To explore more fully the effects of Cdx2 expression on EPC-hTERT cell proliferation, we measured [H 3 ]thymidine incorporation in our EPC-hTERT.D1.Cdx2 cells and EPC-hTERT.D1. MIGR1 cells in the absence and presence of doxycyclin. In the absence of doxycyclin, both cell lines readily incorporated the labeled thymidine. However, when cyclin D1 levels were reduced to baseline by the addition of doxycyclin, thymidine incorporation declined considerably ( Figure 2C) . [H 3 ]Thymidine incorporation by the EPC-hTERT.D1.Cdx2 cells was half that of the controls, suggesting that Cdx2 expression was associated with a significantly reduced rate of cell proliferation when compared with control cells.
We confirmed this finding using the WST-1 assay. EPChTERT.D1.Cdx2 cells accumulated more slowly in culture than the control cells, even when cyclin D1 levels were elevated in the absence of doxycyclin ( Figure 2D ). The addition of doxycyclin further depressed cell numbers in both cell lines. Both of these findings are consistent with our prior observation and probably explain why we were unable to isolate a population of cells stably expressing Cdx2.
We next determined if p53 inactivation would also be permissive for Cdx2 expression in esophageal keratinocytes. We established EPC-hTERT cells expressing a dominant-negative p53 using the pBabe-puro-p53R175H vector ( Figure 3A ) (28) . We then tried again to establish Cdx2 expression using our MIGR-Cdx2 retroviral vector but were unsuccessful. As with the wild-type cells, GFP expression was lost in the dominant-negative p53 cells over 7-10 days after infection, but only in the cells receiving MIGR-Cdx2 and not the control vector MIGR1 (Figure 3B and C) . In summary, an enhanced proliferative stimulus, and not p53 inhibition, is required to overcome the antiproliferative effect of Cdx2 on esophageal keratinocytes. Together, these observations suggest that Cdx2 expression cannot be the first event in the transdifferentiation of esophageal keratinocytes into BE epithelial cells.
Inducing an intestinal pattern of gene expression in human esophageal keratinocytes requires chromatin remodeling in addition to Cdx2 activity The homeodomain transcription factor Cdx2 is an important regulator of the intestinal cell phenotype including both columnar cell morphology and intestine-specific gene expression (10) . After establishing Cdx2 expression in our EPC-hTERT.D1 cells, we evaluated the cells for evidence of intestinalization. By phase contrast and transmission electron microscopy, we observed no significant changes in the morphology of EPC-hTERT.D1.Cdx2 cells when compared with controls (data not shown). We next explored for changes in gene expression patterns that would be consistent with intestinalization. Using quantitative SYBR-green real-time RT-PCR, we tested a panel of genes known to be either Cdx2 transcriptional targets including carbonic anhydrase I (CAI), liver-intestine cadherin (LI-cadherin), lactase-phlorizin hydrolase (LPH), sucrase-isomaltase (SI), claudin-2 and guanylyl cyclase C (GC-C) or genes whose expression is associated with intestinal epithelium [DRA/SLC26A3, Villin, alkaline phosphatase (ALK PHOS), LI-cadherin, SI, LPH, resistin-like molecule b (RELM-b), NHE2, CEACAM6, MUC2 and cytokeratin 20 (KRT20)] for increases in their mRNA levels with Cdx2 expression. In only one gene, CA1, we observed a robust 7-fold increase in mRNA levels associated with Cdx2 ( Figure 4A ). In the others, there was either no change or no detectable mRNA for that gene (data not shown). This observation stands in contrast to our experience in colon cancer and intestinal cell lines, where Cdx2 expression is associated with robust intestinalization (26, 36) . It also is quite different from HET1A cells, where Cdx2 expression alone was sufficient to induce a number of intestine-specific and known Cdx2 target genes (22) . It suggests that Cdx2 expression alone is insufficient to induce intestinal transdifferentiation of normal esophageal keratinocytes.
We next sought to determine if other treatments could be applied to the EPC-hTERT.D1.Cdx2 cells to foster intestinalization. Acid exposure of normal murine esophageal keratinocytes, as well as colon and esophageal cancer cells, has modulated cell differentiation and proliferation (13, 14, 19, 20, 37) . We attempted to replicate this work with our human EPC-hTERT.D1 cells, with and without Cdx2 expression. However, all acid treatments (pH 3.5 or 5.0 for 15 min or 1 h, respectively) uniformly killed the cells (data not shown).
We then considered the possibility that epigenetic processes might be involved in the intestinal transdifferentiation (38) (39) (40) (41) (42) (43) . Treatment of cells with agents such as 5-AzaC is known to induce chromatin remodeling and can foster cell transdifferentiation (44) (45) (46) (47) (48) . We treated our EPC-hTERT.D1.Cdx2 and EPC-hTERT.D1.MIGR1 control cells with increasing doses of 5-AzaC for different lengths of time. We isolated total RNA and performed quantitative RT-PCR for our marker genes.
The 5-AzaC treatment enhanced the expression of several previously unexpressed (DRA/SLC26A3, LPH, KRT20 and CEACAM6) and poorly expressed genes (NHE2 and Villin) ( Figure 4A ). We further determined that 1 lM of 5-AzaC for 10 days or 5 lM for 5 days both yield highly reproducible responses (data not shown). Of the genes tested, there were four patterns of response. One group did not respond to the Cdx2 ± 5-AzaC treatment (LI-cadherin, ALK PHOS, SI, MUC2 and GC-C) (data not shown). Four genes, Claudin-2, CEACAM6, Villin and LPH, were all significantly increased by the 5-AzaC treatment, but Cdx2 expression had no additional effect on their levels ( Figure 4A ).
In the remaining five genes studied, there was clear evidence of a synergistic interaction between Cdx2 and 5-AzaC. mRNA levels for CAI, which were increased 7-fold with Cdx2 expression alone and only 2-fold at best when treated with 5-AzaC, increased by 35-fold above controls when both treatments were applied. Most interesting of all, four genes responded only to the combination of Cdx2 expression and 5-AzaC treatment (RELM-b, NHE2, KRT20 and DRA/SLC26A3). One of these genes, KRT20, is utilized as a marker for BE. Its induction is therefore of great interest.
Cdx1 and Cdx2 expression in the esophagus has been reportedly induced in esophageal keratinocytes by chromatin remodeling agents (22) . We confirmed these findings in our EPC-hTERT.D1.MIGR1 cells, as 5-AzaC treatment induced CDX1 mRNA .20-fold and CDX2 mRNA by nearly 200-fold ( Figure 4C ). However, despite this significant increase in mRNA levels, it did not necessarily translate into increased protein levels. CDX1 and CDX2 protein remained undetectable in the EPC-hTERT.D1.MIGR1 after 5-AzaC treatment ( Figure 4D) . Surprisingly, CDX1 mRNA and protein were detected in the EPC-hTERT.D1.CDX2 cells before the addition of 5-AzaC. This was unexpected; however, the CDX transcription factors are known in the intestine to have auto-and cross-regulatory activity.
Protein levels for other genes of interest also did not typically match the measured mRNA responses. CDX2 expression had no apparent effect on SLC26a3/DRA protein levels. Both SLC26a3/DRA and villin protein levels increased only with 5-AzaC treatment ( Figure  4D and E). NHE2 protein levels did appear to increase modestly when EPC-hTERT.D1.Cdx2 cells were treated with 5-AzaC compared with 
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controls; however, these levels did not reach the 6-fold induction noted in the mRNA levels. In summary, treatments that alter epigenetic gene regulation in esophageal keratinocytes can augment Cdx2's effects and lead to stable mRNA expression of many intestine-specific genes. However, protein levels do not correlate with mRNA levels in EPC-hTERT cells treated with 5-AzaC.
Gene expression patterns of 5-AzaC-treated EPC-hTERT.D1-Cdx2 cells mimic BE The patterns of genes induced in EPC-hTERT.D1-Cdx2 cells after 5-AzaC treatment did resemble those reported previously for human BE. The induction of mRNA expression for genes such as KRT20, LPH, CAI and Villin is consistent with BE, based on prior reports (49) (50) (51) . However, there were no reports for BE-associated induction of NHE2 or DRA/SLC26a3, though both are highly expressed in intestinal epithelium. We therefore investigated for their possible induction in human BE tissue specimens.
Total RNA was isolated from five paired biopsies from BE tissue and adjacent normal squamous epithelium. Quantitative real-time SYBR-green RT-PCR was then performed for two well-described markers for BE (CAI and KRT20) as well as NHE2 and DRA/ SLC26a3. In each case, there was a significant increase in the mRNA levels for these four genes in the BE samples when compared with the control normal adjacent esophageal epithelium ( Figure 5A ). In four of five specimens, there was a 50-to 100-fold increase in NHE2 mRNA levels in BE tissues. DRA/SLC26a3 was increased several 1000-fold in BE tissues compared with normal controls. Similarly, we observed several 100-to several 1000-fold induction of KRT20 and CAI mRNA levels in the BE samples when compared with controls.
To confirm that these increased mRNA levels yield significant increases in protein expression, we stained two BE biopsy specimens for DRA/SL26a3 and NHE2 by immunohistochemistry. Robust DRA/ SLC26a3 and NHE2 protein expression is detected in both biopsy specimens and the normal colon tissues, but not in the normal esophagus control ( Figure 5B ). Taken together, these findings suggest that both NHE2 and DRA/SLC26a3 genes are induced in BE. More importantly, it suggests that the intestinalization induced in EPC-hTERT.D1-Cdx2 cells treated with 5-AzaC may mimic BE transdifferentiation, as two novel BE-associated markers were identified using this approach.
Senescence is activated by the chromatin remodeling agent 5-AzaC in EPC-hTERT.D1-Cdx2 and control esophageal keratinocytes After 5-AzaC treatment, EPC2.hTERT.D1-Cdx2 and MIGR1 control cells exhibit altered cell morphology marked by increased cell volume and subconfluent growth arrest in the normal growth medium. The cells no longer increased in number, despite several days of fresh growth medium. Even low doses of 5-AzaC (1 mM for 72 h) appeared to lead to growth arrest. Additionally, BrdU labeling and WST-1 assays for cell proliferation both suggested that proliferation was absent (data not shown). These features are all suggestive of cell senescence (52) .
In fact, 5-AzaC treatment has been associated with cell senescence in other cell systems (52) . Therefore, to determine whether 5-AzaCtreated cells were undergoing senescence, we evaluated for the induction of senescence-associated b-galactosidase as well as the expression of p21(Waf1/Cip1) and p16(INK4a), all of which are genetic features of senescence. 5-AzaC treatment induced a flattened and enlarged cell morphology in both EPC-hTERT.D1-Cdx2 and EPC-hTERT.D1-MIGR1 cells. Moreover, senescence-associated b-galactosidase activity was markedly increased ( Figure 6A ). p21 and p16INK4a protein levels were greatly increased with 5-AzaC treatment when compared with untreated controls ( Figure 6B ). This increase was not affected by Cdx2 coexpression and is consistent with the induction of senescence. In summary, 5-AzaC treatment of hTERT-immortalized but not transformed human esophageal keratinocytes induces their senescence and withdrawal from the cell cycle.
Discussion BE occurs at the gastroesophageal junction and is the replacement of the normal squamous esophageal mucosa with an intestinalized columnar epithelium. It arises in the setting of chronic acid and bile reflux that results in chronic injury and inflammation in the esophageal epithelium. BE has a relatively high progression rate to EAC. This rate has been estimated to be 0.5-1%/year (2). Thus, it is a clinically important condition to understand.
Esophageal epithelium development and BE
Little is known about the molecular mechanisms giving rise to BE from normal squamous esophageal mucosa. The emergence of the specialized columnar epithelium, characteristic of BE, within a stratified squamous epithelium has been difficult to explain. Indeed, even the identity of the progenitor cell that gives rise to BE epithelium remains controversial. Four candidate progenitor cells have been proposed, but there is as yet no consensus around any one of them (4). Our work is based on the hypothesis that BE arises from squamous cell progenitors. We believe there is a great deal of support for this model in the literature.
Studies of human embryology reveal that at 10 weeks of age, the human esophagus is lined by a columnar epithelium. This epithelium is later replaced by a stratified squamous epithelium, which begins in the mid-esophagus and proceeds in both caudad and cephalad directions (53) . Interactions between the endodermal and mesodermal layers in part control this transdifferentiation into squamous cells (54) (55) (56) . In fact, the regional identity of the early endoderm (foregut versus midgut) is very plastic. Co-culture experiments have established that primitive endoderm will differentiate to match the regional identity (foregut or midgut) of the mesoderm with which it is cultured. Thus, it is possible that one or more progenitor cells within the adult esophageal epithelium may retain this early multipotent capability. This is further supported by the observation of hamartomatous polyps with morphologies consistent with squamous, gastric and intestinal epithelium (57, 58) that arise in Cdx2 (þ/À) heterozygous knockout mice. Theoretically, early progenitor cells with developmental plasticity could differentiate into squamous or glandular epithelium, depending upon local environmental cues and certain disease conditions. 
Cdx2 transdifferentiation of esophageal keratinocytes
One limitation in the study of BE has been the absence of suitable experimental models. We have approached this limitation by determining if normal esophageal keratinocytes can transdifferentiate into intestinal epithelium using a combination of genetic and biochemical manipulations. This forward genetics approach has been used before with great success in the study of cancerous transformation of normal cells (59) . Recently, Liu et al. (22) reported that immortalized human esophageal keratinocytes (HET1A) were intestinalized by expression of the intestine-specific transcription factor Cdx2. That suggested that Cdx2 expression might be associated with increased cell proliferation and an intestinal pattern of gene expression. However, HET1A cells are immortalized by the expression of the SV40 T antigen, which inactivates p53 and pRb function and is associated with altered DNA methylation patterns. These effects may have unintended consequences. For instance, inactivating p53 mutations are acquired late in BE, not with the onset of the intestinal cell phenotype (60) . Moreover, normal pRb function is critical for the antiproliferative effect of Cdx1 (61) . Thus, its inactivation may alter normal cell responses to Cdx2 expression. Lastly, the SV40 T antigen has been associated with changes in DNA methylation patterns in several cell lines (62) . The SV40 T antigen might therefore be masking important early steps in the process of intestinal transdifferentiation. Our findings, reported here, confirm this hypothesis.
Cdx2 expression in human esophageal keratinocytes inhibits proliferation and does not induce an intestinal morphology or pattern of gene expression We utilized for our studies EPC-hTERT cells, normal human esophageal keratinocytes immortalized by the ectopic expression of human telomerase (hTERT) (24) . We demonstrated that Cdx2 expression was not normally maintained in EPC-hTERT cells. Ectopic cyclin D1 expression, but not p53 inhibition, was permissive for long-term Cdx2 expression in EPC-hTERT cells (Figure 2) .
We further determined that this was due to a significant antiproliferative effect that Cdx2 expression had upon EPC-hTERT keratinocytes. This finding was unexpected, as Cdx2 expression in HET1A cells is associated with increased cell proliferation (22) . We believe this difference is due to the abrogation of the pRb function by the SV40 T antigen in HET1A cells. Studies by us and others suggest that the pRb is critical for Cdx2's antiproliferative effect (31, 35, 61) . In the absence of normal pRb function, Cdx appears to have a proproliferative activity.
We then looked for evidence of intestinalization in our EPChTERT.D1.Cdx2 cells. Again, unlike the experience reported with HET1A cells, Cdx2 expression alone in EPC-hTERT cells did not induce an intestinal cell morphology or an intestinal pattern of gene expression. Together, these findings indicate the expression of SV40 T antigen significantly altered keratinocyte response to Cdx2 gene expression.
Changes in DNA methylation and inhibition of cell senescence required for Cdx2-mediated intestinalization of normal human keratinocytes Since Cdx2 expression alone was insufficient for the induction of intestinalization of EPC-hTERT cells, we tried different culture conditions. Many studies suggest that disordered DNA CpG island methylation contributes to the pathogenesis of BE and its associated dysplasia (38-43), we considered whether modulation of DNA methylation would enhance Cdx2-mediated intestinalization.
CpG methylation is believed to determine whether chromatin is in an open, transcriptionally competent conformation or in a state in which it is compacted and closed-off from transcriptional regulators (63) . Agents like 5-AzaC inhibit DNA methyltransferase and globally reduce DNA methylation. Treatment of our EPC-hTERT.D1.Cdx2 cells and controls with 5-AzaC did significantly alter gene expression patterns. More importantly, there were several intestine-specific and BE-associated genes whose expression only increased with the combination of DNA demethtylation and Cdx2 expression. Two of these genes, DRA/SLC26A3 and NHE2, were not previously known to be elevated in BE. Utilizing human BE tissue samples, we confirmed that they were elevated. Thus, our model of esophageal keratinocyte transdifferentiation does appear to mimic the process of intestinal metaplasia seen in BE.
Unexpectedly, we also found that cell senescence was induced in our cells with 5-AzaC treatment. This effect has been reported previously (52) . It is the reason our treated cells no longer proliferated and also probably explains the discordance between mRNA and protein levels we observed after treatment ( Figure 4D ). However, this finding also suggests that important molecular controls exist to prohibit wide-spread epigenetic changes in normal cells. If changes in DNA methylation patterns are essential for initiation of intestinalization in esophageal keratinocytes, then either they must be acquired slowly, so as not to trigger cell senescence, or alternatively the cell senescence mechanism must be inactivated prior to the acquisition of significant changes in DNA methylation. This might be the case, as the tumor suppressor and senescence-associated p16 gene is silenced by promoter hypermethylation early in BE pathogenesis, preceding the onset of dysplasia (64) . If cell senescence is indeed inactivated, it argues that a normal mechanism of tumor suppression is dysfunctional in BE cells, and it may explain why the transition to neoplasia occurs more frequently in BE tissues than in the normal esophagus.
Molecular model for BE
Based on our findings, we propose a stepwise model for the earliest molecular events in the progression from normal squamous esophageal epithelium to BE ( Figure 6C ). Chronic acid and bile reflux induce inflammation, both acute and chronic. Inflammatory mediators induce repair mechanisms that promote cell proliferation of basal cells. Reactive oxygen species liberated by the injury cause oxidative stress and DNA damage, resulting in changes in DNA methylation patterns of all cells including stem cells. These epigenetic changes lead to the induction of Cdx1 and Cdx2 expression and ultimately the activation of an intestinal program for cell differentiation. In theory, intestinalized cells expressing intestinal mucins would better tolerate the acid and bile acid injury caused by gastric reflux and therefore have a competitive advantage, permitting them to replace the squamous epithelium. However, given our unexpected induction of cell senescence with 5-AzaC, we further hypothesize that these pro-proliferative and epigenetic events run the risk of activating tumor suppressor mechanisms like cell senescence in normal epithelial cells. Therefore, these Barrett's supportive changes are either acquired in a manner that does not trigger tumor suppressors or critical tumor suppressors are inactivated during this process (i.e. p16 silencing by hypermethylation). Additional studies on human Barrett's samples are needed to clarify the role of tumor suppressor mechanisms in the earliest stages of BE.
In summary, BE can arise from normal esophageal keratinocyte precursors, but requires several molecular events including enhanced cell proliferation, inhibition of cell senescence and epigenetic changes in order for the induction of intestinal metaplasia to occur. Characterizing these early steps in the progression will give us further insights into the molecular pathogenesis of BE and may suggest novel therapeutic and preventative strategies to better treat patients with this condition.
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